Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-067286
Filing Date
2025-05-09
Accepted
2025-05-08 18:16:08
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tsbx-20250331.htm   iXBRL 10-Q 2308959
2 EX-10.1 tsbx-ex10_1.htm EX-10.1 383520
3 EX-31.1 tsbx-ex31_1.htm EX-31.1 15657
4 EX-31.2 tsbx-ex31_2.htm EX-31.2 15887
5 EX-32.1 tsbx-ex32_1.htm EX-32.1 10536
  Complete submission text file 0000950170-25-067286.txt   10242240

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20250331.xsd EX-101.SCH 1498495
82 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20250331_htm.xml XML 1745425
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41747 | Film No.: 25927728
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)